NEW YORK, March 18, 2010 – Canon U.S.A, Inc., a leader in digital imaging solutions, will demonstrate the benefits of using its total digital imaging and workflow management solutions, including the CX-1 Hybrid Digital Mydriatic/Non-Mydriatic Retinal Camera1, during Vision Expo East, March 19th – 21st, at the Jacob K. Javits Convention Center in New York (booth # MS1050).
The CX-1 is the Company's first fully hybrid digital retinal camera with both mydriatic and non-mydriatic modes. With one touch, the operator can automatically switch between mydriatic and non-mydriatic modes, effortlessly utilizing different functions within seconds and performing several concurrent ocular tests.
The Canon CX-1 Hybrid Digital Mydriatic/Non-Mydriatic Retinal Camera allows the user to take one-shot FAF (Fundus Autofluorescence) photography in a standard configuration, for both mydriatic and non-mydriatic modes. Fundus autofluorescence, or FAF, is the occurrence of autofluorescence in macular waste, particularly Lipofuscin. Examinations that check and monitor autofluorescent waste material are a key step in AMD detection. Using the non-mydriatic mode not only saves time and resources, it also can make the diagnostic procedure more comfortable for the patient.
"Canon continues to provide ophthalmic professionals with the latest digital imaging technology, helping them to provide comprehensive, high-end care to their patients," said Tsuneo Imai, senior director and general manager, Medical Systems Division, Canon U.S.A. "At Vision Expo East, Canon will demonstrate how our full line of digital imaging solutions for the ophthalmic world can play a significant role in improving the efficiency of eye care exams and the management of patient data and images."